Ivermectin Does Not Alleviate Mild Covid 19 Symptoms Study Finds The New York Times

By switzerlandersing On Sep 10, 2025

Ivermectin Does Not Reduce Risk Of Covid Hospitalization, Large Study Finds - The New York Times

Ivermectin Does Not Reduce Risk Of Covid Hospitalization, Large Study Finds - The New York Times Ivermectin does not speed recovery in people with mild cases of covid 19, according to a randomized controlled trial published in the journal jama today. Among adults with mild covid 19, a 5 day course of ivermectin, compared with placebo, did not significantly improve the time to resolution of symptoms. the findings do no ….

Ivermectin Doesn't Prevent Severe Disease From Covid-19, New Study Finds - CNN

Ivermectin Doesn't Prevent Severe Disease From Covid-19, New Study Finds - CNN Randomized clinical trials have repeatedly found that ivermectin does not benefit covid 19 patients. the national institutes of health recommends against its use for covid 19. A study led by the duke clinical research institute (dcri) in partnership with vanderbilt university found no differences in relief of mild to moderate covid 19 symptoms between participants taking ivermectin and participants taking a placebo. Ivermectin, an anti parasitic drug often used to deworm horses and cattle, does not reduce the risk of being hospitalized with covid 19 despite its questionable rise as an alternative treatment for the disease, according to a large new study published in the new england journal of medicine. Ivermectin, an antiparasitic drug that became popular as an alternative treatment for covid 19, showed no signs of quelling the disease or reducing patients’ risk of hospitalization, according to results from a large clinical trial published in the new england journal of medicine.

Ivermectin Does Not Alleviate Mild Covid-19 Symptoms, Study Finds - The New York Times

Ivermectin Does Not Alleviate Mild Covid-19 Symptoms, Study Finds - The New York Times Ivermectin, an anti parasitic drug often used to deworm horses and cattle, does not reduce the risk of being hospitalized with covid 19 despite its questionable rise as an alternative treatment for the disease, according to a large new study published in the new england journal of medicine. Ivermectin, an antiparasitic drug that became popular as an alternative treatment for covid 19, showed no signs of quelling the disease or reducing patients’ risk of hospitalization, according to results from a large clinical trial published in the new england journal of medicine. A new study published in the new england journal of medicine shows ivermectin does not protect against covid 19 hospitalizations. here's what researchers hope people will take away from the findings. A 2024 randomized controlled trial found that ivermectin resulted in statistically significant lower viral load in mild to moderate covid 19 patients, but notably had no significant effect on clinical symptoms [2]. Despite early studies suggesting potential, the principle trial's findings – published in the journal of infection indicate that ivermectin does not lead to clinically significant improvements in covid 19 recovery times, hospital admissions, or mortality rates. A new study, which looked at more than 1,300 people infected with the coronavirus, effectively ruled out ivermectin as a useful treatment for covid, the researchers said.